secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAIA Biotechnology, Inc. (MAIA)
CIK:        0001878313
Form:       8-K
Filed at:   2025-02-25T23:59:59+00:00
Accession:  0001493152-25-008137
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MAIA Biotechnology raises ~$1.43M private placement, total $4.1M from two deals
-------------------------------------------------------------------------------

- 952,300 shares at $1.50 each; warrants exercisable at $1.85 for 6 years, starting 1 year post-issuance.
- Company directors participate (58,333 shares); proceeds to fund Part C of Phase 2 THIO-101 trial and working capital.
- Combined gross proceeds from this and a separate $2.7M placement (closed Feb 24) reach $4.1M.
- Private placement expected to close on or about February 26, 2025, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1878313/000149315225008137/0001493152-25-008137-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1878313/000149315225008137/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-008137

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer